These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25331369)

  • 1. A prospective observational study of oseltamivir safety and tolerability in infants and young children ≤24 months.
    Rath BA; Blumentals WA; Miller MK; Starzyk K; Tetiurka B; Wollenhaupt M
    Pharmacoepidemiol Drug Saf; 2015 Mar; 24(3):286-96. PubMed ID: 25331369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and safety of intravenous oseltamivir in infants and children in open-label studies.
    Muñoz FM; Anderson EJ; Deville JG; Clinch B; Kamal MA
    Int J Clin Pharmacol Ther; 2015 Jul; 53(7):531-40. PubMed ID: 26042486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of Japanese infants younger than 3 months who were treated with oseltamivir for influenza: safety of oseltamivir treatment.
    Morioka I; Nonoyama S; Tanaka-Taya K; Ihara T; Sugaya N; Ueta I; Kumagai T; Okada K; Hosoya M; Okabe N; Morishima T;
    Scand J Infect Dis; 2012 Aug; 44(8):605-9. PubMed ID: 22497443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Compliance and safety of oseltamivir treatment in children and infants less than one year of age].
    Tasher D; Bishop B; Stein M; Somekh E
    Harefuah; 2012 Aug; 151(8):450-4, 499. PubMed ID: 23350287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oseltamivir for treatment of influenza in infants less than one year: a retrospective analysis.
    Siedler K; Skopnik H
    Pediatr Infect Dis J; 2010 Jun; 29(6):495-8. PubMed ID: 20035245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, virology and pharmacokinetics of oseltamivir in infants with laboratory-confirmed influenza: a Phase I/II, prospective, open-label, multicentre clinical trial.
    Rath BA; Brzostek J; Guillén S; Niranjan V; Chappey C; Rayner CR; Clinch B
    Antivir Ther; 2015; 20(8):815-25. PubMed ID: 26015411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features, oseltamivir treatment and outcome in infants aged <12 months with laboratory-confirmed influenza A in 2009.
    Khandaker G; Zurynski Y; Lester-Smith D; Kesson A; Heron L; Dwyer DE; Elliott EJ; Booy R
    Antivir Ther; 2011; 16(7):1005-10. PubMed ID: 22024516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability of a 6-week course of oseltamivir prophylaxis for seasonal influenza in children.
    Reisinger K; Shu D; Cupelli L; Marcadis I; Dutkowski R
    Influenza Other Respir Viruses; 2013 Jan; 7(1):11-3. PubMed ID: 22520945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza and oseltamivir phosphate (Tamiflu) in infants: what you need to know.
    Mortada M; Neuenschwander P; Tekko SS
    Pediatr Nurs; 2014; 40(1):16-20. PubMed ID: 24757915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled trial evaluating the safety of early oseltamivir treatment among children 0-9 years of age hospitalized with influenza in El Salvador and Panama.
    Dawood FS; Jara J; Gonzalez R; Castillo JM; De León T; Estripeaut D; Luciani K; Sujey Brizuela Y; Barahona A; Cazares RA; Lawson AM; Rodriguez M; de Viana D; Franco D; Castillo M; Fry AM; Gubareva L; Tamura D; Hughes M; Gargiullo P; Clara W; Azziz-Baumgartner E; Widdowson MA
    Antiviral Res; 2016 Sep; 133():85-94. PubMed ID: 27451343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oseltamivir use in infants under one year of age: are there still unanswered questions?
    Kara A; Karadağ-Oncel E; Ozkaya-Parlakay A; Korukluoğlu G; Bağdat A; Celik M; Ceyhan M; Cengiz AB
    Turk J Pediatr; 2012; 54(1):25-9. PubMed ID: 22397038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-marketing assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: an updated review.
    Toovey S; Prinssen EP; Rayner CR; Thakrar BT; Dutkowski R; Koerner A; Chu T; Sirzen-Zelenskaya A; Britschgi M; Bansod S; Donner B
    Adv Ther; 2012 Oct; 29(10):826-48. PubMed ID: 23054689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of oral oseltamivir for influenza prophylaxis in transplant recipients.
    Ison MG; Szakaly P; Shapira MY; Kriván G; Nist A; Dutkowski R
    Antivir Ther; 2012; 17(6):955-64. PubMed ID: 22728756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Birth outcomes among women exposed to neuraminidase inhibitors during pregnancy.
    Svensson T; Granath F; Stephansson O; Kieler H
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1030-4. PubMed ID: 21774030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial.
    Wang C; Cao B; Liu QQ; Zou ZQ; Liang ZA; Gu L; Dong JP; Liang LR; Li XW; Hu K; He XS; Sun YH; An Y; Yang T; Cao ZX; Guo YM; Wen XM; Wang YG; Liu YL; Jiang LD
    Ann Intern Med; 2011 Aug; 155(4):217-25. PubMed ID: 21844547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and pharmacokinetics of oseltamivir for prophylaxis of neonates exposed to influenza H1N1.
    Maltezou HC; Drakoulis N; Siahanidou T; Karalis V; Zervaki E; Dotsikas Y; Loukas YL; Theodoridou M
    Pediatr Infect Dis J; 2012 May; 31(5):527-9. PubMed ID: 22209917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of infants exposed to oseltamivir or zanamivir in utero during pandemic (H1N1) 2009.
    Saito S; Minakami H; Nakai A; Unno N; Kubo T; Yoshimura Y
    Am J Obstet Gynecol; 2013 Aug; 209(2):130.e1-9. PubMed ID: 23583838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety profile of oseltamivir during the 2009 influenza pandemic.
    Donner B; Bader-Weder S; Schwarz R; Peng MM; Smith JR; Niranjan V
    Pharmacoepidemiol Drug Saf; 2011 May; 20(5):532-43. PubMed ID: 21448900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment.
    Smith JR; Sacks S
    Int J Clin Pract; 2009 Apr; 63(4):596-605. PubMed ID: 19335705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.